EMEA (Europe, Middle East and Africa) Pharma Excipients Market Report 2017

December 2017 | 109 pages | ID: E9302856774EN
QYResearch

Abstracts

In this report, the EMEA Pharma Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Pharma Excipients for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pharma Excipients market competition by top manufacturers/players, with Pharma Excipients sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Archer Daniels Midland (ADM)
• BASF
• DOW Chemical Company
• Evonik
• J.M. Huber Corporation
• ABITEC Corporation
• Cargill
• Eastman Chemical Company
• AkzoNobel

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Polymers
• Alcohols
• Minerals
• Sugar
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Oral Solid Dosage Forms (OSDF)
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Pharma Excipients Market Report 2017

1 PHARMA EXCIPIENTS OVERVIEW

1.1 Product Overview and Scope of Pharma Excipients
1.2 Classification of Pharma Excipients
  1.2.1 EMEA Pharma Excipients Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Pharma Excipients Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Polymers
  1.2.4 Alcohols
  1.2.5 Minerals
  1.2.6 Sugar
  1.2.7 Others
1.3 EMEA Pharma Excipients Market by Application/End Users
  1.3.1 EMEA Pharma Excipients Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Oral Solid Dosage Forms (OSDF)
  1.3.3 Others
1.4 EMEA Pharma Excipients Market by Region
  1.4.1 EMEA Pharma Excipients Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Pharma Excipients (2012-2022)
  1.5.1 EMEA Pharma Excipients Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Pharma Excipients Revenue and Growth Rate (2012-2022)

2 EMEA PHARMA EXCIPIENTS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Pharma Excipients Market Competition by Players/Manufacturers
  2.1.1 EMEA Pharma Excipients Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Pharma Excipients Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Pharma Excipients Sale Price by Players (2012-2017)
2.2 EMEA Pharma Excipients (Volume and Value) by Type/Product Category
  2.2.1 EMEA Pharma Excipients Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Pharma Excipients Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Pharma Excipients Sale Price by Type (2012-2017)
2.3 EMEA Pharma Excipients (Volume) by Application
2.4 EMEA Pharma Excipients (Volume and Value) by Region
  2.4.1 EMEA Pharma Excipients Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Pharma Excipients Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Pharma Excipients Sales Price by Region (2012-2017)

3 EUROPE PHARMA EXCIPIENTS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Pharma Excipients Sales and Value (2012-2017)
  3.1.1 Europe Pharma Excipients Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Pharma Excipients Revenue and Growth Rate (2012-2017)
3.2 Europe Pharma Excipients Sales and Market Share by Type
3.3 Europe Pharma Excipients Sales and Market Share by Application
3.4 Europe Pharma Excipients Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Pharma Excipients Sales Volume by Countries (2012-2017)
  3.4.2 Europe Pharma Excipients Revenue by Countries (2012-2017)
  3.4.3 Germany Pharma Excipients Sales and Growth Rate (2012-2017)
  3.4.4 France Pharma Excipients Sales and Growth Rate (2012-2017)
  3.4.5 UK Pharma Excipients Sales and Growth Rate (2012-2017)
  3.4.6 Russia Pharma Excipients Sales and Growth Rate (2012-2017)
  3.4.7 Italy Pharma Excipients Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Pharma Excipients Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PHARMA EXCIPIENTS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Pharma Excipients Sales and Value (2012-2017)
  4.1.1 Middle East Pharma Excipients Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Pharma Excipients Revenue and Growth Rate (2012-2017)
4.2 Middle East Pharma Excipients Sales and Market Share by Type
4.3 Middle East Pharma Excipients Sales and Market Share by Application
4.4 Middle East Pharma Excipients Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Pharma Excipients Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Pharma Excipients Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Pharma Excipients Sales and Growth Rate (2012-2017)
  4.4.4 Israel Pharma Excipients Sales and Growth Rate (2012-2017)
  4.4.5 UAE Pharma Excipients Sales and Growth Rate (2012-2017)
  4.4.6 Iran Pharma Excipients Sales and Growth Rate (2012-2017)

5 AFRICA PHARMA EXCIPIENTS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Pharma Excipients Sales and Value (2012-2017)
  5.1.1 Africa Pharma Excipients Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Pharma Excipients Revenue and Growth Rate (2012-2017)
5.2 Africa Pharma Excipients Sales and Market Share by Type
5.3 Africa Pharma Excipients Sales and Market Share by Application
5.4 Africa Pharma Excipients Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Pharma Excipients Sales Volume by Countries (2012-2017)
  5.4.2 Africa Pharma Excipients Revenue by Countries (2012-2017)
  5.4.3 South Africa Pharma Excipients Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Pharma Excipients Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Pharma Excipients Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Pharma Excipients Sales and Growth Rate (2012-2017)

6 EMEA PHARMA EXCIPIENTS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Archer Daniels Midland (ADM)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pharma Excipients Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Archer Daniels Midland (ADM) Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 BASF
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Pharma Excipients Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 BASF Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 DOW Chemical Company
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Pharma Excipients Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 DOW Chemical Company Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Evonik
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Pharma Excipients Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Evonik Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 J.M. Huber Corporation
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Pharma Excipients Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 J.M. Huber Corporation Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 ABITEC Corporation
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Pharma Excipients Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 ABITEC Corporation Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Cargill
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Pharma Excipients Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Cargill Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Eastman Chemical Company
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Pharma Excipients Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Eastman Chemical Company Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 AkzoNobel
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Pharma Excipients Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 AkzoNobel Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 PHARMA EXCIPIENTS MANUFACTURING COST ANALYSIS

7.1 Pharma Excipients Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pharma Excipients

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pharma Excipients Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pharma Excipients Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PHARMA EXCIPIENTS MARKET FORECAST (2017-2022)

11.1 EMEA Pharma Excipients Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Pharma Excipients Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Pharma Excipients Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Pharma Excipients Price and Trend Forecast (2017-2022)
11.2 EMEA Pharma Excipients Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Pharma Excipients Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Pharma Excipients Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Pharma Excipients Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Pharma Excipients Sales Forecast by Type (2017-2022)
11.7 EMEA Pharma Excipients Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pharma Excipients
Figure EMEA Pharma Excipients Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Pharma Excipients Sales Volume Market Share by Type (Product Category) in 2016
Figure Polymers Product Picture
Figure Alcohols Product Picture
Figure Minerals Product Picture
Figure Sugar Product Picture
Figure Others Product Picture
Figure EMEA Pharma Excipients Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Pharma Excipients by Application in 2016
Figure Oral Solid Dosage Forms (OSDF) Examples
Table Key Downstream Customer in Oral Solid Dosage Forms (OSDF)
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Pharma Excipients Market Size (Million USD) by Region (2012-2022)
Figure Europe Pharma Excipients Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Pharma Excipients Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Pharma Excipients Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Pharma Excipients Revenue (Million USD) Status and Forecast by Countries
Figure Africa Pharma Excipients Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Pharma Excipients Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Pharma Excipients Sales Volume and Growth Rate (2012-2022)
Figure EMEA Pharma Excipients Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Pharma Excipients Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Pharma Excipients Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Pharma Excipients Sales Share by Players (2012-2017)
Figure 2016 Pharma Excipients Sales Share by Players
Figure 2017 Pharma Excipients Sales Share by Players
Figure EMEA Pharma Excipients Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Pharma Excipients Revenue (Million USD) by Players (2012-2017)
Table EMEA Pharma Excipients Revenue Share by Players (2012-2017)
Table 2016 EMEA Pharma Excipients Revenue Share by Players
Table 2017 EMEA Pharma Excipients Revenue Share by Players
Table EMEA Pharma Excipients Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Pharma Excipients Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Pharma Excipients Sales Share by Type (2012-2017)
Figure Sales Market Share of Pharma Excipients by Type (2012-2017)
Figure EMEA Pharma Excipients Sales Market Share by Type (2012-2017)
Table EMEA Pharma Excipients Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Pharma Excipients Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pharma Excipients by Type in 2016
Table EMEA Pharma Excipients Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Pharma Excipients Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Pharma Excipients Sales Share by Application (2012-2017)
Figure Sales Market Share of Pharma Excipients by Application (2012-2017)
Figure EMEA Pharma Excipients Sales Market Share by Application in 2016
Table EMEA Pharma Excipients Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Pharma Excipients Sales Share by Region (2012-2017)
Figure Sales Market Share of Pharma Excipients by Region (2012-2017)
Figure EMEA Pharma Excipients Sales Market Share in 2016
Table EMEA Pharma Excipients Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Pharma Excipients Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Pharma Excipients by Region (2012-2017)
Figure EMEA Pharma Excipients Revenue Market Share Regions in 2016
Table EMEA Pharma Excipients Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Pharma Excipients Revenue and Growth Rate (2012-2017)
Table Europe Pharma Excipients Sales (K Units) by Type (2012-2017)
Table Europe Pharma Excipients Market Share by Type (2012-2017)
Figure Europe Pharma Excipients Market Share by Type in 2016
Table Europe Pharma Excipients Sales (K Units) by Application (2012-2017)
Table Europe Pharma Excipients Market Share by Application (2012-2017)
Figure Europe Pharma Excipients Market Share by Application in 2016
Table Europe Pharma Excipients Sales (K Units) by Countries (2012-2017)
Table Europe Pharma Excipients Sales Market Share by Countries (2012-2017)
Figure Europe Pharma Excipients Sales Market Share by Countries (2012-2017)
Figure Europe Pharma Excipients Sales Market Share by Countries in 2016
Table Europe Pharma Excipients Revenue (Million USD) by Countries (2012-2017)
Table Europe Pharma Excipients Revenue Market Share by Countries (2012-2017)
Figure Europe Pharma Excipients Revenue Market Share by Countries (2012-2017)
Figure Europe Pharma Excipients Revenue Market Share by Countries in 2016
Figure Germany Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure France Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure UK Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Pharma Excipients Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Pharma Excipients Sales (K Units) by Type (2012-2017)
Table Middle East Pharma Excipients Market Share by Type (2012-2017)
Figure Middle East Pharma Excipients Market Share by Type (2012-2017)
Table Middle East Pharma Excipients Sales (K Units) by Applications (2012-2017)
Table Middle East Pharma Excipients Market Share by Applications (2012-2017)
Figure Middle East Pharma Excipients Sales Market Share by Application in 2016
Table Middle East Pharma Excipients Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Pharma Excipients Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Pharma Excipients Sales Volume Market Share by Countries in 2016
Table Middle East Pharma Excipients Revenue (Million USD) by Countries (2012-2017)
Table Middle East Pharma Excipients Revenue Market Share by Countries (2012-2017)
Figure Middle East Pharma Excipients Revenue Market Share by Countries (2012-2017)
Figure Middle East Pharma Excipients Revenue Market Share by Countries in 2016
Figure Saudi Arabia Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Pharma Excipients Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Pharma Excipients Sales (K Units) by Type (2012-2017)
Table Africa Pharma Excipients Sales Market Share by Type (2012-2017)
Figure Africa Pharma Excipients Sales Market Share by Type (2012-2017)
Figure Africa Pharma Excipients Sales Market Share by Type in 2016
Table Africa Pharma Excipients Sales (K Units) by Application (2012-2017)
Table Africa Pharma Excipients Sales Market Share by Application (2012-2017)
Figure Africa Pharma Excipients Sales Market Share by Application (2012-2017)
Table Africa Pharma Excipients Sales Volume (K Units) by Countries (2012-2017)
Table Africa Pharma Excipients Sales Market Share by Countries (2012-2017)
Figure Africa Pharma Excipients Sales Market Share by Countries (2012-2017)
Figure Africa Pharma Excipients Sales Market Share by Countries in 2016
Table Africa Pharma Excipients Revenue (Million USD) by Countries (2012-2017)
Table Africa Pharma Excipients Revenue Market Share by Countries (2012-2017)
Figure Africa Pharma Excipients Revenue Market Share by Countries (2012-2017)
Figure Africa Pharma Excipients Revenue Market Share by Countries in 2016
Figure South Africa Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Table Archer Daniels Midland (ADM) Pharma Excipients Basic Information List
Table Archer Daniels Midland (ADM) Pharma Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Archer Daniels Midland (ADM) Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Archer Daniels Midland (ADM) Pharma Excipients Sales Market Share in EMEA (2012-2017)
Figure Archer Daniels Midland (ADM) Pharma Excipients Revenue Market Share in EMEA (2012-2017)
Table BASF Pharma Excipients Basic Information List
Table BASF Pharma Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BASF Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure BASF Pharma Excipients Sales Market Share in EMEA (2012-2017)
Figure BASF Pharma Excipients Revenue Market Share in EMEA (2012-2017)
Table DOW Chemical Company Pharma Excipients Basic Information List
Table DOW Chemical Company Pharma Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure DOW Chemical Company Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure DOW Chemical Company Pharma Excipients Sales Market Share in EMEA (2012-2017)
Figure DOW Chemical Company Pharma Excipients Revenue Market Share in EMEA (2012-2017)
Table Evonik Pharma Excipients Basic Information List
Table Evonik Pharma Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Evonik Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Evonik Pharma Excipients Sales Market Share in EMEA (2012-2017)
Figure Evonik Pharma Excipients Revenue Market Share in EMEA (2012-2017)
Table J.M. Huber Corporation Pharma Excipients Basic Information List
Table J.M. Huber Corporation Pharma Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure J.M. Huber Corporation Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure J.M. Huber Corporation Pharma Excipients Sales Market Share in EMEA (2012-2017)
Figure J.M. Huber Corporation Pharma Excipients Revenue Market Share in EMEA (2012-2017)
Table ABITEC Corporation Pharma Excipients Basic Information List
Table ABITEC Corporation Pharma Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ABITEC Corporation Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure ABITEC Corporation Pharma Excipients Sales Market Share in EMEA (2012-2017)
Figure ABITEC Corporation Pharma Excipients Revenue Market Share in EMEA (2012-2017)
Table Cargill Pharma Excipients Basic Information List
Table Cargill Pharma Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cargill Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Cargill Pharma Excipients Sales Market Share in EMEA (2012-2017)
Figure Cargill Pharma Excipients Revenue Market Share in EMEA (2012-2017)
Table Eastman Chemical Company Pharma Excipients Basic Information List
Table Eastman Chemical Company Pharma Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eastman Chemical Company Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure Eastman Chemical Company Pharma Excipients Sales Market Share in EMEA (2012-2017)
Figure Eastman Chemical Company Pharma Excipients Revenue Market Share in EMEA (2012-2017)
Table AkzoNobel Pharma Excipients Basic Information List
Table AkzoNobel Pharma Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AkzoNobel Pharma Excipients Sales (K Units) and Growth Rate (2012-2017)
Figure AkzoNobel Pharma Excipients Sales Market Share in EMEA (2012-2017)
Figure AkzoNobel Pharma Excipients Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pharma Excipients
Figure Manufacturing Process Analysis of Pharma Excipients
Figure Pharma Excipients Industrial Chain Analysis
Table Raw Materials Sources of Pharma Excipients Major Manufacturers in 2016
Table Major Buyers of Pharma Excipients
Table Distributors/Traders List
Figure EMEA Pharma Excipients Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Pharma Excipients Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Pharma Excipients Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Pharma Excipients Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Pharma Excipients Sales Market Share Forecast by Region (2017-2022)
Table EMEA Pharma Excipients Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Pharma Excipients Revenue Market Share Forecast by Region (2017-2022)
Table Europe Pharma Excipients Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Pharma Excipients Sales Market Share Forecast by Countries (2017-2022)
Table Europe Pharma Excipients Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Pharma Excipients Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Pharma Excipients Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Pharma Excipients Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Pharma Excipients Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Pharma Excipients Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Pharma Excipients Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Pharma Excipients Sales Market Share Forecast by Countries (2017-2022)
Table Africa Pharma Excipients Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Pharma Excipients Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Pharma Excipients Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Pharma Excipients Sales Market Share Forecast by Type (2017-2022)
Table EMEA Pharma Excipients Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Pharma Excipients Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources